Get access

Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia

Authors


Paloma Perez-Aciego, Avda, Manoteras 50-52 28 050, Madrid, Spain. Tel.: 34 91 38 41 989; Fax: 34 91 38 30 068;
E-mail: paloma_perez@cilsp.com

Summary

In the last few years, it has been suggested that the involvement of human leukocyte antigen-G (HLA-G) in several tumoral processes and its likely participation as a factor of immune tolerance in malignant cells. Recently, positive HLA-G surface expression has been associated with a poor prognosis in a small group of patients with B-cell chronic lymphocytic leukemia (B-CLL), a lymphoproliferative disorder characterized by a heterogeneous clinical course. In the present work, 169 patients suffering from B-CLL were analyzed for the expression of HLA-G by flow cytometry in order to verify its prognostic value in a larger cohort. We observed a low expression of this molecule on leukemic B cells and no significant relation to clinical data or progression-free survival time, indicating that this molecule is not as good immunologic prognostic marker for B-CLL as suggested.

Ancillary